Multifactorial Intervention on Diabetes (MIDiab Study)

• Status: Recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The prevalence of diabetes mellitus has been increasing in recent decades in China, and vascular complication is the major burden in patients with type 2 diabetes. Previous studies demonstrated that only glycemic control was not effective enough to prevent or improve diabetic vascular complications, but guidelines from the Chinese Diabetes Society and other national guidelines recommend an integrated multifactorial treatment approach. In this study, we aim to evaluate the effect on diabetic vascular complications of a multifactorial intervention comprising behavior modification, polypharmacological therapy and periodical monitoring in patients with type 2 diabetes.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shandong Provincial Hospital
• Collaborators: Beijing Hospital, National Center of Gerontology; First Affiliated Hospital of Air Force Military Medical University; Fujian Medical University Union Hospital; Inner Mongolia People's Hospital; The Affiliated Hospital of Inner Mongolia Medical University; The Affiliated Hospital of Qingdao University; The First Hospital of Jilin University; The First People's Hospital of Yinchuan; The Fourth Affiliated Hospital of Harbin Medical University; Yantai Yuhuangding Hospital Affiliated to Qingdao University

Criteria

Inclusion Criteria:

1. 35-75 years old;

2. diagnosed as type 2 diabetes according to the criteria of the World Health Organization in 1999.

Exclusion Criteria:

1. type 1 diabetes，specific types of diabetes，gestational diabetes or pregestational diabetes;

2. acute cardiovascular or cerebrovascular accidents within past 3 months;

3. severe hepatic or renal dysfunction;

4. malignant tumor;

5. allergic history or contraindication for any drugs in trials;

6. taking part in other clinical trials;

7. obviously poor compliance.